• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Timberlake appointed as Berkshire Biomedical CEO

April 27, 2021 By Sean Whooley

Berkshire BiomedicalBerkshire Biomedical announced today that it appointed John E. Timberlake as its new president and CEO.

Dallas-based Berkshire Biomedical, which develops a virtual care prescription drug delivery and management system, also added Timberlake to its advisory board, according to a news release.

The COPA system is designed to offer virtual care delivery using technology combined with data along with medication self-administration and adherence.

“We are delighted to welcome John to the Berkshire Biomedical team.  His extensive leadership experience within the healthcare industry will be instrumental as we move toward the introduction of the COPA system, our virtual care prescription drug delivery and management solution,” Berkshire Biomedical co-founder & chairman Thomas M. Rouse said in the release.  “John’s experience with early-stage team building is an excellent fit for Berkshire at this stage of our growth.  John’s in-depth industry knowledge and network will be particularly important as we continue work to identify and execute collaborations with strategic partners and we transition from a product development company to a product marketing company.”

Timberlake, a veteran of more than 30 years in the life sciences space, most recently served as CEO, president and board member at Valeritas, having worked at the company for 14 years before executing its sale to Zealand Pharma in April 2020.

He also held varying leadership roles at Sanofi and its predecessor companies, including a number of key positions in creating the company’s diabetes franchise.

“This is an exciting time to join Berkshire Biomedical as the COPA system addresses the intersection of two great needs in the healthcare ecosystem — the drive for virtual care led by technology and data and the imperative to improve medical adherence,” Timberlake said. “I look forward to bringing my years of experience to bear in advancing the commercialization of this innovative system both through strategic partnerships and through our own channels.  I am confident we will be successful bringing this potentially game-changing virtual care prescription drug delivery and management system to the market as we position Berkshire to be a leader in healthcare innovation.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured Tagged With: Berkshire Biomedical, Personnel, Personnel Moves

IN CASE YOU MISSED IT

  • Abbott could pave new roads in diabetes management with dual sensor on the horizon
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS